Media Inquiries

If you are interested in interviewing a CCR scientist, OR you are a scientist who has been contacted by a member of the media, please contact the NCI Press Office at ncipressofficers@mail.nih.gov or by phone at 240.760.6600.

Clinical Trials

Clinical trial researches CAR T-cell therapy for hairy cell leukemia

Robert J. Kreitman, M.D., Senior Investigator in the Laboratory of Molecular Biology, is leading a study to see whether CAR T-cell therapy impacts patients with hairy cell leukemia.

Clinical trials research immunotherapy for Kaposi sarcoma

Clinical trials led by Ramya Ramaswami, M.B.B.S., M.P.H., Physician-Scientist Early Investigator in the HIV and AIDS Malignancy Branch, are researching immunotherapy for Kaposi sarcoma.

Male patient discusses pain with female doctor

Clinical trial researching PSMA imaging in prostate cancer

A clinical trial led by Deborah E. Citrin, M.D., Senior Investigator in the Radiation Oncology Branch, is researching prostate-specific membrane antigen (PSMA) imaging to evaluate response to radiation treatment in patients with prostate cancer.

Clinical trial researching therapy for some small cell lung cancers

Anish Thomas, M.B.B.S., M.D., Lasker Clinical Research Scholar in the Developmental Therapeutics Branch, is leading NCI’s participation in a trial researching therapies for small cell lung cancer.

Clinical trial researches therapy for VEXAS syndrome

A clinical trial led by Dennis Hickstein, M.D., Senior Investigator in the Immune Deficiency Cellular Therapy Program, is researching a therapy for people with VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) syndrome.

Clinical trial researches three-part immunotherapy regimen for gastric or head and neck cancer

Jason M. Redman, M.D., Assistant Research Physician in the Genitourinary Malignancies Branch, is leading a study researching a three-part immunotherapy regimen in adults with gastric or head and neck cancer.

A series of images depicting computed tomography (CT) scans of prostate cancer.

Clinical trial aims to reduce hormone therapy side effects for people with prostate cancer

A team at CCR is investigating a new device to deliver hormone therapy directly into prostate cancer tumors. The approach could improve patient quality of life by reducing burdensome side effects of current hormone therapies.

First-in-human clinical trial evaluates drug for pancreatic cancer and other solid tumors

Christine Alewine, M.D., Ph.D., a Lasker Clinical Research Scholar in the Laboratory of Molecular Biology, is leading CCR participation in a first-in-human trial to evaluate a drug for therapy of pancreatic cancer and other solid tumors. The drug aims to attack a physical barrier that helps to hide the tumor from the body’s immune system.

Steven Pavletic named Top Ten Clinical Research Achievement awardee

Steven Z. Pavletic, M.D., M.S., Senior Clinician in the Immune Deficiency Cellular Therapy Program, has been named a Top Ten Clinical Research Achievement awardee by the Clinical Research Forum for his study “A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.”

Clinical trial studies combination therapy for relapsed/refractory B-cell lymphomas

Burkitt lymphoma and diffuse large B-cell lymphoma are fast-growing cancers, and new therapies are needed for adults whose disease is not effectively treated with chemotherapy alone. Investigators at CCR are studying a combination therapy as a potential treatment for people with these aggressive cancers.

Breadcrumb

Clinical Trials